ArticleiScience2025

Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system.

Max Mendez-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.